194 related articles for article (PubMed ID: 4686386)
1. Prostaglandin E2 and the luteal phase of the menstrual cycle: effects on blood progesterone, estradiol, cortisol, and growth hormone levels.
Henzl MR; Ortega E; Cortés-Gallegos V; Tomlinson RV; Segre EJ
J Clin Endocrinol Metab; 1973 Apr; 36(4):784-7. PubMed ID: 4686386
[TBL] [Abstract][Full Text] [Related]
2. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
3. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
4. Intravenous infusion of prostaglandin F2alpha in the mid-luteal phase of the normal human menstrual cycle.
Jewelewicz R; Cantor B; Dyrenfurth I; Warren MP; Vande Wiele RL
Prostaglandins; 1972 Jun; 1(6):443-51. PubMed ID: 4660079
[No Abstract] [Full Text] [Related]
5. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
[TBL] [Abstract][Full Text] [Related]
6. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
7. Luteolysis in humans and subhuman primates.
Henzl MR
Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
[TBL] [Abstract][Full Text] [Related]
8. The effect of prostaglandin F2 alpha infusion on corpus luteum function.
Jones GS; Wentz AG
Am J Obstet Gynecol; 1972 Oct; 114(3):393-404. PubMed ID: 4637460
[TBL] [Abstract][Full Text] [Related]
9. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
Arrata WS; Chatterton RT
Am J Obstet Gynecol; 1974 Dec; 120(7):954-9. PubMed ID: 4429112
[TBL] [Abstract][Full Text] [Related]
10. Effect of indomethacin on estrogen-induced luteolysis in the ewe.
Lewis PE; Warren JE
Prostaglandins; 1977 May; 13(5):957-63. PubMed ID: 866703
[TBL] [Abstract][Full Text] [Related]
11. Intraluteal infusion of a prostaglandin synthesis inhibitor, sodium meclofenamate, causes premature luteolysis in rhesus monkeys.
Sargent EL; Baughman WL; Novy MJ; Stouffer RL
Endocrinology; 1988 Nov; 123(5):2261-9. PubMed ID: 3168922
[TBL] [Abstract][Full Text] [Related]
12. The effect of vaginally administered prostaglandin F2alpha on corpus luteum function.
Bolognese RJ; Corson SL
Am J Obstet Gynecol; 1973 Sep; 117(2):240-5. PubMed ID: 4728875
[TBL] [Abstract][Full Text] [Related]
13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
14. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
[TBL] [Abstract][Full Text] [Related]
16. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
[TBL] [Abstract][Full Text] [Related]
17. Serum ovarian steroids, prolactin and prostaglandin metabolites in women using the inert intrauterine device.
Shalev E; Harpaz-Kerpel S; Engelhard Y; Weiner E; Eran A; Zuckerman H
Int J Gynaecol Obstet; 1987 Apr; 25(2):139-44. PubMed ID: 2884139
[TBL] [Abstract][Full Text] [Related]
18. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
19. Effect of PGF2alpha in pseudopregnancy.
Wentz AC; Rocco L; Jones GS
Obstet Gynecol; 1975 Jan; 45(1):49-55. PubMed ID: 1110819
[TBL] [Abstract][Full Text] [Related]
20. Plasma steroid and luteinizing hormone levels during prostaglandin F 2 administration in luteal phase of menstrual cycle.
Hillier K; Dutton A; Corker CS; Singer A; Embrey MP
Br Med J; 1972 Nov; 4(5836):333-6. PubMed ID: 4637514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
